应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06955 博安生物
休市中 11-22 16:08:13
8.080
-0.510
-5.94%
最高
8.540
最低
7.510
成交量
37.34万
今开
8.440
昨收
8.590
日振幅
11.99%
总市值
43.30亿
流通市值
43.30亿
总股本
5.36亿
成交额
304.43万
换手率
0.07%
流通股本
5.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
博安生物盘中异动 股价大跌6.05%报8.070港元
市场透视 · 11-22 14:32
博安生物盘中异动 股价大跌6.05%报8.070港元
博安生物(06955)股价下跌5.163%,现价港币$8.45
阿斯达克财经 · 11-15
博安生物(06955)股价下跌5.163%,现价港币$8.45
博安生物(06955)上涨5.14%,报9.2元/股
金融界 · 11-14
博安生物(06955)上涨5.14%,报9.2元/股
博安生物盘中异动 大幅上涨5.14%
市场透视 · 11-14
博安生物盘中异动 大幅上涨5.14%
【券商聚焦】中泰证券首予博安生物(06955)“增持”评级 指布局品种上市进度在同类产品中领先
金吾财讯 · 11-12
【券商聚焦】中泰证券首予博安生物(06955)“增持”评级 指布局品种上市进度在同类产品中领先
博安生物盘中异动 股价大跌5.59%
市场透视 · 11-12
博安生物盘中异动 股价大跌5.59%
博安生物(06955)下跌6.9%,报8.5元/股
金融界 · 11-12
博安生物(06955)下跌6.9%,报8.5元/股
博安生物(06955)上涨5.09%,报9.7元/股
金融界 · 10-24
博安生物(06955)上涨5.09%,报9.7元/股
博安生物盘中异动 早盘大幅上涨5.09%报9.700港元
市场透视 · 10-24
博安生物盘中异动 早盘大幅上涨5.09%报9.700港元
博安生物盘中异动 股价大涨5.84%报9.790港元
市场透视 · 10-18
博安生物盘中异动 股价大涨5.84%报9.790港元
博安生物(06955)下跌5.05%,报9.4元/股
金融界 · 10-14
博安生物(06955)下跌5.05%,报9.4元/股
博安生物盘中异动 临近收盘急速下跌5.05%
市场透视 · 10-14
博安生物盘中异动 临近收盘急速下跌5.05%
博安生物(06955)上涨14.2%,报11.1元/股
金融界 · 10-10
博安生物(06955)上涨14.2%,报11.1元/股
博安生物盘中异动 大幅拉升5.14%
市场透视 · 10-10
博安生物盘中异动 大幅拉升5.14%
博安生物(06955)股价上升5.144%,现价港币$10.22
阿斯达克财经 · 10-10
博安生物(06955)股价上升5.144%,现价港币$10.22
博安生物盘中异动 早盘股价大涨5.09%报10.740港元
市场透视 · 10-09
博安生物盘中异动 早盘股价大涨5.09%报10.740港元
博安生物(06955)上涨21.78%,报11.8元/股
金融界 · 10-08
博安生物(06955)上涨21.78%,报11.8元/股
博安生物盘中异动 股价大涨5.06%
市场透视 · 10-08
博安生物盘中异动 股价大涨5.06%
博安生物盘中异动 早盘急速上涨7.22%
市场透视 · 09-30
博安生物盘中异动 早盘急速上涨7.22%
营收利润双丰收却遭港股通“遗忘”,博安生物何以撬起估值?
智通财经 · 09-27
营收利润双丰收却遭港股通“遗忘”,博安生物何以撬起估值?
加载更多
公司概况
公司名称:
博安生物
所属市场:
SEHK
上市日期:
--
主营业务:
山东博安生物技术股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事治疗用抗体的开发、生产和商业化,专注于肿瘤学、代谢学、自身免疫学和眼科等治疗领域。该公司主要拥有三个技术平台:全人抗体转基因小鼠及噬菌体展示技术平台、双特异T-cell Engager技术平台、抗体药物偶联(ADC)技术平台。该公司主要在中国国内市场和海外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"06955","market":"HK","secType":"STK","nameCN":"博安生物","latestPrice":8.08,"timestamp":1732262893022,"preClose":8.59,"halted":0,"volume":373400,"delay":0,"floatShares":535933694,"shares":535933694,"eps":-0.2513683,"marketStatus":"休市中","marketStatusCode":7,"change":-0.51,"latestTime":"11-22 16:08:13","open":8.44,"high":8.54,"low":7.51,"amount":3044308,"amplitude":0.119907,"askPrice":8.08,"askSize":6800,"bidPrice":8.02,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":0.13014630241084843,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"listingDate":1672329600000,"adjPreClose":8.59,"openAndCloseTimeList":[[1732239000000,1732248000000],[1732251600000,1732262400000]],"volumeRatio":1.7914028007341762,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06955","defaultTab":"news","newsList":[{"id":"2485286580","title":"博安生物盘中异动 股价大跌6.05%报8.070港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485286580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485286580?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:32","pubTimestamp":1732257144,"startTime":"0","endTime":"0","summary":"2024年11月22日下午盘14时32分,博安生物股票出现波动,股价急速跳水6.05%。截至发稿,该股报8.070港元/股,成交量17.7万股,换手率0.03%,振幅5.47%。资金方面,该股资金流入61.4878万港元,流出53.001万港元。博安生物股票所在的生物技术行业中,整体跌幅为1.49%。其相关个股中,迈博药业-B、云康集团、晶泰科技涨幅较大,振幅较大的相关个股有华领医药-B、云康集团、来凯医药-B,振幅分别为16.67%、14.00%、13.83%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122143224971a80c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122143224971a80c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2483396817","title":"博安生物(06955)股价下跌5.163%,现价港币$8.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2483396817","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483396817?lang=zh_cn&edition=full","pubTime":"2024-11-15 11:19","pubTimestamp":1731640740,"startTime":"0","endTime":"0","summary":"[下跌股]博安生物(06955) 股价在上午11:19比前收市价下跌5.163%,现股价为港币$8.45。至目前为止,今日最高价为$8.99,而最低价为$8.45。总成交量为22.46万股,总成交金额为港币$195.927万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD241115796/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2483954418","title":"博安生物(06955)上涨5.14%,报9.2元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483954418","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483954418?lang=zh_cn&edition=full","pubTime":"2024-11-14 10:53","pubTimestamp":1731552792,"startTime":"0","endTime":"0","summary":"11月14日,博安生物(06955)盘中上涨5.14%,截至10:53,报9.2元/股,成交211.89万元。山东博安生物技术股份有限公司是一家生物制药公司,主要业务包括生物药开发、生产和商业化,特别专注于肿瘤、自身免疫、眼科和代谢疾病领域。目前,公司拥有三款商业化产品,已在中国及包括欧美在内的海外市场进行生物药产品开发,并有几个在研的创新生物药和生物类似药产品组合,已构建起全覆盖“研发-生产-商业化”的产业价值链运营体系。截至2024年中报,博安生物营业总收入3.63亿元、净利润6167.2万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14105345278508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2483891835","title":"博安生物盘中异动 大幅上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483891835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483891835?lang=zh_cn&edition=full","pubTime":"2024-11-14 10:53","pubTimestamp":1731552786,"startTime":"0","endTime":"0","summary":"2024年11月14日早盘10时53分,博安生物股票出现异动,股价大幅拉升5.14%。截至发稿,该股报9.200港元/股,成交量23.66万股,换手率0.04%,振幅5.49%。博安生物股票所在的生物技术行业中,整体跌幅为1.14%。其相关个股中,晶泰科技、康宁杰瑞制药-B、中国抗体-B涨幅较大,振幅较大的相关个股有晶泰科技、康宁杰瑞制药-B、中国抗体-B,振幅分别为33.13%、13.33%、12.15%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114105306971a6727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114105306971a6727&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2482710978","title":"【券商聚焦】中泰证券首予博安生物(06955)“增持”评级 指布局品种上市进度在同类产品中领先","url":"https://stock-news.laohu8.com/highlight/detail?id=2482710978","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482710978?lang=zh_cn&edition=full","pubTime":"2024-11-12 12:21","pubTimestamp":1731385308,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰证券发研报指,博安生物 生物类似药上市品种不断累积及放量,2021/2022/2023年收入分别达到1.6、5.2、6.2亿元,2024年上半年收入达到3.6亿元,公司规模效应初现,销售费用率、管理费用率及研发费用率在2024年上半年分别为40.4%、6.7%、23.6%,相比2023年明显优化,由此在2024年上半年公司实现了首次盈利。公司已布局的生物类似药在同类产品中领先,有望把握住原研专利过期后的关键市场窗口期,商业化前景向好。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947548","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955","600918"],"gpt_icon":0},{"id":"2482715796","title":"博安生物盘中异动 股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482715796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482715796?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:39","pubTimestamp":1731379193,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘10时39分,博安生物股票出现波动,股价急速下跌5.59%。截至发稿,该股报8.620港元/股,成交量14.16万股,换手率0.03%,振幅6.68%。资金方面,该股资金流入5.8116万港元,流出65.7128万港元。博安生物股票所在的生物技术行业中,整体涨幅为1.40%。其相关个股中,药明合联、奥星生命科技、中国抗体-B涨幅较大,振幅较大的相关个股有绿竹生物-B、药明合联、和誉-B,振幅分别为18.42%、17.14%、12.23%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112103953971a5df8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112103953971a5df8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2482715079","title":"博安生物(06955)下跌6.9%,报8.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482715079","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482715079?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:38","pubTimestamp":1731379105,"startTime":"0","endTime":"0","summary":"11月12日,博安生物(06955)盘中下跌6.9%,截至10:38,报8.5元/股,成交122.97万元。山东博安生物技术股份有限公司是一家生物制药公司,主要业务包括生物药开发、生产和商业化,特别专注于肿瘤、自身免疫、眼科和代谢疾病领域。目前,公司拥有三款商业化产品,已在中国及包括欧美在内的海外市场进行生物药产品开发,并有几个在研的创新生物药和生物类似药产品组合,已构建起全覆盖“研发-生产-商业化”的产业价值链运营体系。截至2024年中报,博安生物营业总收入3.63亿元、净利润6167.2万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/12103845180528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2477204543","title":"博安生物(06955)上涨5.09%,报9.7元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477204543","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477204543?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:21","pubTimestamp":1729736471,"startTime":"0","endTime":"0","summary":"10月24日,博安生物(06955)盘中上涨5.09%,截至10:21,报9.7元/股,成交174.88万元。山东博安生物技术股份有限公司是一家生物制药公司,主要业务包括生物药开发、生产和商业化,特别专注于肿瘤、自身免疫、眼科和代谢疾病领域。目前,公司拥有三款商业化产品,已在中国及包括欧美在内的海外市场进行生物药产品开发,并有几个在研的创新生物药和生物类似药产品组合,已构建起全覆盖“研发-生产-商业化”的产业价值链运营体系。截至2024年中报,博安生物营业总收入3.63亿元、净利润6167.2万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/24102144375248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2477548248","title":"博安生物盘中异动 早盘大幅上涨5.09%报9.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477548248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477548248?lang=zh_cn&edition=full","pubTime":"2024-10-24 10:21","pubTimestamp":1729736465,"startTime":"0","endTime":"0","summary":"2024年10月24日早盘10时21分,博安生物股票出现异动,股价急速上涨5.09%。截至发稿,该股报9.700港元/股,成交量18.3万股,换手率0.03%,振幅4.55%。资金方面,该股资金流入134.262万港元,流出3.0688万港元。博安生物股票所在的生物技术行业中,整体跌幅为1.27%。其相关个股中,复旦张江、博安生物、宜明昂科-B涨幅较大,振幅较大的相关个股有来凯医药-B、复旦张江、方达控股,振幅分别为11.73%、10.62%、10.29%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024102105971a1ecc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024102105971a1ecc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2476249258","title":"博安生物盘中异动 股价大涨5.84%报9.790港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476249258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476249258?lang=zh_cn&edition=full","pubTime":"2024-10-18 09:32","pubTimestamp":1729215125,"startTime":"0","endTime":"0","summary":"2024年10月18日早盘09时32分,博安生物股票出现波动,股价大幅上涨5.84%。截至发稿,该股报9.790港元/股,成交量4400股,换手率0.00%,振幅9.51%。资金方面,该股资金流入1.7726万港元,流出9100港元。博安生物股票所在的生物技术行业中,整体跌幅为0.65%。其相关个股中,来凯医药-B、博安生物、宜明昂科-B涨幅较大,振幅较大的相关个股有博安生物、来凯医药-B、和誉-B,振幅分别为9.51%、9.48%、3.39%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018093205971a0ee8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018093205971a0ee8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2475395273","title":"博安生物(06955)下跌5.05%,报9.4元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475395273","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475395273?lang=zh_cn&edition=full","pubTime":"2024-10-14 15:41","pubTimestamp":1728891669,"startTime":"0","endTime":"0","summary":"10月14日,博安生物(06955)盘中下跌5.05%,截至15:41,报9.4元/股,成交521.26万元。山东博安生物技术股份有限公司主要从事生物药的开发、生产和商业化,专注于肿瘤、自身免疫、眼科和代谢疾病的新药研发。公司目前已有三款商业化产品和多个在研的创新型生物药及生物类似药,运营覆盖研发、生产,到商业化的全产业链,并在中国和海外市场开展业务。截至2024年中报,博安生物营业总收入3.63亿元、净利润6167.2万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/14154143964548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2475339730","title":"博安生物盘中异动 临近收盘急速下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475339730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475339730?lang=zh_cn&edition=full","pubTime":"2024-10-14 15:41","pubTimestamp":1728891667,"startTime":"0","endTime":"0","summary":"2024年10月14日临近收盘15时41分,博安生物股票出现波动,股价急速下跌5.05%。截至发稿,该股报9.400港元/股,成交量54.46万股,换手率0.10%,振幅9.90%。博安生物股票所在的生物技术行业中,整体跌幅为2.65%。其相关个股中,正大企业国际、盛禾生物-B、来凯医药-B涨幅较大,振幅较大的相关个股有创胜集团-B、荃信生物-B、来凯医药-B,振幅分别为27.19%、25.07%、21.22%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101415410798e3c39d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101415410798e3c39d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2474750432","title":"博安生物(06955)上涨14.2%,报11.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474750432","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474750432?lang=zh_cn&edition=full","pubTime":"2024-10-10 13:17","pubTimestamp":1728537426,"startTime":"0","endTime":"0","summary":"10月10日,博安生物(06955)盘中上涨14.2%,截至13:17,报11.1元/股,成交486.8万元。山东博安生物技术股份有限公司主要从事生物药的开发、生产和商业化,专注于肿瘤、自身免疫、眼科和代谢疾病的新药研发。公司目前已有三款商业化产品和多个在研的创新型生物药及生物类似药,运营覆盖研发、生产,到商业化的全产业链,并在中国和海外市场开展业务。截至2024年中报,博安生物营业总收入3.63亿元、净利润6167.2万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/10131743869089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2474750553","title":"博安生物盘中异动 大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474750553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474750553?lang=zh_cn&edition=full","pubTime":"2024-10-10 13:15","pubTimestamp":1728537308,"startTime":"0","endTime":"0","summary":"2024年10月10日下午盘13时15分,博安生物股票出现异动,股价急速上涨5.14%。截至发稿,该股报10.220港元/股,成交量37.78万股,换手率0.07%,振幅5.35%。博安生物股票所在的生物技术行业中,整体涨幅为1.64%。其相关个股中,锦欣生殖、科济药业-B、华康生物医学涨幅较大,振幅较大的相关个股有科济药业-B、三叶草生物-B、北海康成-B,振幅分别为17.56%、14.86%、14.55%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010131508ab690dba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010131508ab690dba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2474750486","title":"博安生物(06955)股价上升5.144%,现价港币$10.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2474750486","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474750486?lang=zh_cn&edition=full","pubTime":"2024-10-10 13:15","pubTimestamp":1728537300,"startTime":"0","endTime":"0","summary":"[上升股]博安生物(06955) 股价在下午01:15比前收市价上升5.144%,现股价为港币$10.22。至目前为止,今日最高价为$10.22,而最低价为$9.7。总成交量为37.78万股,总成交金额为港币$377.847万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2410106257/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2474253544","title":"博安生物盘中异动 早盘股价大涨5.09%报10.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474253544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474253544?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:44","pubTimestamp":1728438272,"startTime":"0","endTime":"0","summary":"2024年10月09日早盘09时44分,博安生物股票出现异动,股价急速拉升5.09%。截至发稿,该股报10.740港元/股,成交量23.12万股,换手率0.04%,振幅4.89%。资金方面,该股资金流入81.9828万港元,流出114.802万港元。博安生物股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,北海康成-B、科笛-B、绿竹生物-B涨幅较大,振幅较大的相关个股有药明巨诺-B、创胜集团-B、昭衍新药,振幅分别为14.78%、10.00%、9.55%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009094432ab68a246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009094432ab68a246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2473500644","title":"博安生物(06955)上涨21.78%,报11.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473500644","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473500644?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:43","pubTimestamp":1728351814,"startTime":"0","endTime":"0","summary":"10月8日,博安生物(06955)盘中上涨21.78%,截至09:43,报11.8元/股,成交509.84万元。山东博安生物技术股份有限公司主要从事生物药的开发、生产和商业化,专注于肿瘤、自身免疫、眼科和代谢疾病的新药研发。公司目前已有三款商业化产品和多个在研的创新型生物药及生物类似药,运营覆盖研发、生产,到商业化的全产业链,并在中国和海外市场开展业务。截至2024年中报,博安生物营业总收入3.63亿元、净利润6167.2万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/08094343751865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2473945797","title":"博安生物盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473945797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473945797?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:30","pubTimestamp":1728351043,"startTime":"0","endTime":"0","summary":"2024年10月08日早盘09时30分,博安生物股票出现波动,股价快速拉升5.06%。截至发稿,该股报10.180港元/股,成交量5.28万股,换手率0.01%,振幅3.41%。资金方面,该股资金流入9.7024万港元,流出1.6288万港元。博安生物股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,宜明昂科-B、圣诺医药-B、来凯医药-B涨幅较大,振幅较大的相关个股有复旦张江、药明生物、嘉和生物-B,振幅分别为8.88%、7.00%、6.41%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008093043a1dec8cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008093043a1dec8cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2471157878","title":"博安生物盘中异动 早盘急速上涨7.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471157878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471157878?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:30","pubTimestamp":1727659835,"startTime":"0","endTime":"0","summary":"2024年09月30日早盘09时30分,博安生物股票出现波动,股价快速拉升7.22%。截至发稿,该股报10.400港元/股,成交量3600股,换手率0.00%,振幅0.82%。博安生物股票所在的生物技术行业中,整体涨幅为1.43%。其相关个股中,北海康成-B、康宁杰瑞制药-B、荣昌生物涨幅较大,振幅较大的相关个股有康宁杰瑞制药-B、荣昌生物、方达控股,振幅分别为24.18%、7.12%、6.67%。该公司在中国和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093009303698e398f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093009303698e398f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2470294779","title":"营收利润双丰收却遭港股通“遗忘”,博安生物何以撬起估值?","url":"https://stock-news.laohu8.com/highlight/detail?id=2470294779","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470294779?lang=zh_cn&edition=full","pubTime":"2024-09-27 16:48","pubTimestamp":1727426913,"startTime":"0","endTime":"0","summary":"博安生物在财报中表示,收入的增长证明其能够持续将生物制品产品组合推向市场并维持市场份额。截至本公告日期,博安生物的三款产品已在中国大陆成功上市并覆盖逾2700家目标医院及机构。然而,博安生物目前面临的问题在于其生物类似药产品商业化业绩难以撑起其后期管线研发与商业化运营。截至今年6月末,公司现金及现金等价物1.72亿元,现金压力依旧存在。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092716533795815f5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092716533795815f5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06955","HSCEI","HSTECH"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.boan-bio.com","stockEarnings":[{"period":"1week","weight":-0.0734},{"period":"1month","weight":-0.1246},{"period":"3month","weight":-0.0992},{"period":"6month","weight":-0.1441},{"period":"1year","weight":-0.484},{"period":"ytd","weight":-0.4787}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0737},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.0736},{"period":"ytd","weight":0.128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"山东博安生物技术股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事治疗用抗体的开发、生产和商业化,专注于肿瘤学、代谢学、自身免疫学和眼科等治疗领域。该公司主要拥有三个技术平台:全人抗体转基因小鼠及噬菌体展示技术平台、双特异T-cell Engager技术平台、抗体药物偶联(ADC)技术平台。该公司主要在中国国内市场和海外市场开展其业务。","exchange":"SEHK","name":"博安生物","nameEN":"BOAN BIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博安生物(06955)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博安生物(06955)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博安生物,06955,博安生物股票,博安生物股票老虎,博安生物股票老虎国际,博安生物行情,博安生物股票行情,博安生物股价,博安生物股市,博安生物股票价格,博安生物股票交易,博安生物股票购买,博安生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博安生物(06955)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博安生物(06955)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}